New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version)
Abstract The diagnostic criteria for slowly progressive type 1 diabetes (slowly progressive insulin‐dependent diabetes mellitus; SPIDDM) have been revised by the Committee on Type 1 Diabetes of the Japan Diabetes Society. All of the following three criteria must be met for ‘a definitive diagnosis of...
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-02-01
|
| Series: | Journal of Diabetes Investigation |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/jdi.14121 |
| _version_ | 1827376058836451328 |
|---|---|
| author | Akira Shimada Eiji Kawasaki Norio Abiru Takuya Awata Yoichi Oikawa Haruhiko Osawa Hiroshi Kajio Junji Kozawa Kazuma Takahashi Daisuke Chujo Shinsuke Noso Tomoyasu Fukui Junnosuke Miura Kazuki Yasuda Hisafumi Yasuda Akihisa Imagawa Hiroshi Ikegami |
| author_facet | Akira Shimada Eiji Kawasaki Norio Abiru Takuya Awata Yoichi Oikawa Haruhiko Osawa Hiroshi Kajio Junji Kozawa Kazuma Takahashi Daisuke Chujo Shinsuke Noso Tomoyasu Fukui Junnosuke Miura Kazuki Yasuda Hisafumi Yasuda Akihisa Imagawa Hiroshi Ikegami |
| author_sort | Akira Shimada |
| collection | DOAJ |
| description | Abstract The diagnostic criteria for slowly progressive type 1 diabetes (slowly progressive insulin‐dependent diabetes mellitus; SPIDDM) have been revised by the Committee on Type 1 Diabetes of the Japan Diabetes Society. All of the following three criteria must be met for ‘a definitive diagnosis of SPIDDM’: (1) presence of anti‐islet autoantibodies at some point in time during the disease course; (2) absence of ketosis or ketoacidosis at the diagnosis of diabetes with no requirement for insulin treatment to correct hyperglycemia immediately after diagnosis in principle; and (3) gradual decrease of insulin secretion over time, with insulin treatment required at more than 3 months after diagnosis, and the presence of severe endogenous insulin deficiency (fasting serum C‐peptide immunoreactivity <0.6 ng/mL) at the last observed point in time. When a patient fulfills only (1) and (2), but not (3), he/she is diagnosed with ‘SPIDDM (probable)’ because the diabetes is non‐insulin‐dependent type. |
| first_indexed | 2024-03-08T12:03:57Z |
| format | Article |
| id | doaj.art-b3d704e5e6444179a72e157a102250d0 |
| institution | Directory Open Access Journal |
| issn | 2040-1116 2040-1124 |
| language | English |
| last_indexed | 2024-03-08T12:03:57Z |
| publishDate | 2024-02-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Diabetes Investigation |
| spelling | doaj.art-b3d704e5e6444179a72e157a102250d02024-01-23T13:16:32ZengWileyJournal of Diabetes Investigation2040-11162040-11242024-02-0115225425710.1111/jdi.14121New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version)Akira Shimada0Eiji Kawasaki1Norio Abiru2Takuya Awata3Yoichi Oikawa4Haruhiko Osawa5Hiroshi Kajio6Junji Kozawa7Kazuma Takahashi8Daisuke Chujo9Shinsuke Noso10Tomoyasu Fukui11Junnosuke Miura12Kazuki Yasuda13Hisafumi Yasuda14Akihisa Imagawa15Hiroshi Ikegami16Department of Endocrinology and Diabetes, School of Medicine Saitama Medical University Saitama JapanDiabetes Center Shin‐Koga Hospital Fukuoka JapanMidori Clinic Nagasaki JapanPancreatic Islet Cell Transplantation Center National Center for Global Health and Medicine Tokyo JapanDepartment of Endocrinology and Diabetes, School of Medicine Saitama Medical University Saitama JapanDepartment of Diabetes and Molecular Genetics Ehime University Graduate School of Medicine Ehime JapanDepartment of Diabetes, Endocrinology and Metabolism Center Hospital of the National Center for Global Health and Medicine Tokyo JapanDepartment of Diabetes Care Medicine Graduate School of Medicine, Osaka University Osaka JapanDepartment of Basic Nursing Science, School of Nursing Iwate Prefectural University Iwate JapanCenter for Clinical Research Toyama University Hospital Toyama JapanDepartment of Endocrinology, Metabolism and Diabetes Kindai University Faculty of Medicine Osaka JapanDepartment of Medicine, Division of Diabetes, Metabolism and Endocrinology Showa University School of Medicine Tokyo JapanDivision of Diabetology and Metabolism, Department of Internal Medicine Tokyo Women's Medical University School of Medicine Tokyo JapanDepartment of Diabetes, Endocrinology and Metabolism Kyorin University School of Medicine Tokyo JapanDepartment of Public Health, Division of Health Sciences Kobe University Graduate School of Health Sciences Hyogo JapanDepartment of Internal Medicine (I), Faculty of Medicine Osaka Medical and Pharmaceutical University Osaka JapanDepartment of Endocrinology, Metabolism and Diabetes Kindai University Faculty of Medicine Osaka JapanAbstract The diagnostic criteria for slowly progressive type 1 diabetes (slowly progressive insulin‐dependent diabetes mellitus; SPIDDM) have been revised by the Committee on Type 1 Diabetes of the Japan Diabetes Society. All of the following three criteria must be met for ‘a definitive diagnosis of SPIDDM’: (1) presence of anti‐islet autoantibodies at some point in time during the disease course; (2) absence of ketosis or ketoacidosis at the diagnosis of diabetes with no requirement for insulin treatment to correct hyperglycemia immediately after diagnosis in principle; and (3) gradual decrease of insulin secretion over time, with insulin treatment required at more than 3 months after diagnosis, and the presence of severe endogenous insulin deficiency (fasting serum C‐peptide immunoreactivity <0.6 ng/mL) at the last observed point in time. When a patient fulfills only (1) and (2), but not (3), he/she is diagnosed with ‘SPIDDM (probable)’ because the diabetes is non‐insulin‐dependent type.https://doi.org/10.1111/jdi.14121GAD antibodyLatent autoimmune diabetes in adultsSlowly progressive type 1 diabetes |
| spellingShingle | Akira Shimada Eiji Kawasaki Norio Abiru Takuya Awata Yoichi Oikawa Haruhiko Osawa Hiroshi Kajio Junji Kozawa Kazuma Takahashi Daisuke Chujo Shinsuke Noso Tomoyasu Fukui Junnosuke Miura Kazuki Yasuda Hisafumi Yasuda Akihisa Imagawa Hiroshi Ikegami New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version) Journal of Diabetes Investigation GAD antibody Latent autoimmune diabetes in adults Slowly progressive type 1 diabetes |
| title | New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version) |
| title_full | New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version) |
| title_fullStr | New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version) |
| title_full_unstemmed | New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version) |
| title_short | New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version) |
| title_sort | new diagnostic criteria 2023 for slowly progressive type 1 diabetes spiddm report from committee on type 1 diabetes of the japan diabetes society english version |
| topic | GAD antibody Latent autoimmune diabetes in adults Slowly progressive type 1 diabetes |
| url | https://doi.org/10.1111/jdi.14121 |
| work_keys_str_mv | AT akirashimada newdiagnosticcriteria2023forslowlyprogressivetype1diabetesspiddmreportfromcommitteeontype1diabetesofthejapandiabetessocietyenglishversion AT eijikawasaki newdiagnosticcriteria2023forslowlyprogressivetype1diabetesspiddmreportfromcommitteeontype1diabetesofthejapandiabetessocietyenglishversion AT norioabiru newdiagnosticcriteria2023forslowlyprogressivetype1diabetesspiddmreportfromcommitteeontype1diabetesofthejapandiabetessocietyenglishversion AT takuyaawata newdiagnosticcriteria2023forslowlyprogressivetype1diabetesspiddmreportfromcommitteeontype1diabetesofthejapandiabetessocietyenglishversion AT yoichioikawa newdiagnosticcriteria2023forslowlyprogressivetype1diabetesspiddmreportfromcommitteeontype1diabetesofthejapandiabetessocietyenglishversion AT haruhikoosawa newdiagnosticcriteria2023forslowlyprogressivetype1diabetesspiddmreportfromcommitteeontype1diabetesofthejapandiabetessocietyenglishversion AT hiroshikajio newdiagnosticcriteria2023forslowlyprogressivetype1diabetesspiddmreportfromcommitteeontype1diabetesofthejapandiabetessocietyenglishversion AT junjikozawa newdiagnosticcriteria2023forslowlyprogressivetype1diabetesspiddmreportfromcommitteeontype1diabetesofthejapandiabetessocietyenglishversion AT kazumatakahashi newdiagnosticcriteria2023forslowlyprogressivetype1diabetesspiddmreportfromcommitteeontype1diabetesofthejapandiabetessocietyenglishversion AT daisukechujo newdiagnosticcriteria2023forslowlyprogressivetype1diabetesspiddmreportfromcommitteeontype1diabetesofthejapandiabetessocietyenglishversion AT shinsukenoso newdiagnosticcriteria2023forslowlyprogressivetype1diabetesspiddmreportfromcommitteeontype1diabetesofthejapandiabetessocietyenglishversion AT tomoyasufukui newdiagnosticcriteria2023forslowlyprogressivetype1diabetesspiddmreportfromcommitteeontype1diabetesofthejapandiabetessocietyenglishversion AT junnosukemiura newdiagnosticcriteria2023forslowlyprogressivetype1diabetesspiddmreportfromcommitteeontype1diabetesofthejapandiabetessocietyenglishversion AT kazukiyasuda newdiagnosticcriteria2023forslowlyprogressivetype1diabetesspiddmreportfromcommitteeontype1diabetesofthejapandiabetessocietyenglishversion AT hisafumiyasuda newdiagnosticcriteria2023forslowlyprogressivetype1diabetesspiddmreportfromcommitteeontype1diabetesofthejapandiabetessocietyenglishversion AT akihisaimagawa newdiagnosticcriteria2023forslowlyprogressivetype1diabetesspiddmreportfromcommitteeontype1diabetesofthejapandiabetessocietyenglishversion AT hiroshiikegami newdiagnosticcriteria2023forslowlyprogressivetype1diabetesspiddmreportfromcommitteeontype1diabetesofthejapandiabetessocietyenglishversion |